000 01083 a2200337 4500
005 20250516022426.0
264 0 _c20110922
008 201109s 0 0 eng d
022 _a1434-9949
024 7 _a10.1007/s10067-011-1688-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPehlivan, Yavuz
245 0 0 _aUrotensin-II in systemic sclerosis: a new peptide in pathogenesis.
_h[electronic resource]
260 _bClinical rheumatology
_cJun 2011
300 _a837-42 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCase-Control Studies
650 0 4 _aEndothelin-1
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aScleroderma, Systemic
_xblood
650 0 4 _aSeverity of Illness Index
650 0 4 _aUrotensins
_xblood
700 1 _aOnat, Ahmet Mesut
700 1 _aComez, Gazi
700 1 _aBabacan, Taner
773 0 _tClinical rheumatology
_gvol. 30
_gno. 6
_gp. 837-42
856 4 0 _uhttps://doi.org/10.1007/s10067-011-1688-3
_zAvailable from publisher's website
999 _c20554493
_d20554493